€22.06
0.09% yesterday
Xetra, May 16, 05:35 pm CET
ISIN
DE000A288904
Symbol
COP
Index

CompuGroup Medical Target price 2025 - Analyst rating & recommendation

CompuGroup Medical Classifications & Recommendation:

Buy
25%
Hold
50%
Sell
25%

CompuGroup Medical Price Target

Target Price €23.75
Price €22.06
Potential
Number of Estimates 4
4 Analysts have issued a price target CompuGroup Medical 2026 . The average CompuGroup Medical target price is €23.75. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 1 Analysts recommend CompuGroup Medical to buy, 2 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CompuGroup Medical stock has an average upside potential 2026 of . Most analysts recommend the CompuGroup Medical stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion € 1.15 1.19
2.83% 3.26%
EBITDA Margin 17.44% 20.03%
23.55% 14.84%
Net Margin 3.00% 4.66%
21.64% 55.13%

4 Analysts have issued a sales forecast CompuGroup Medical 2025 . The average CompuGroup Medical sales estimate is

€1.2b
Unlock
. This is
3.26% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€1.2b 4.72%
Unlock
, the lowest is
€1.2b 2.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €1.2b 2.83%
2025
€1.2b 3.26%
Unlock
2026
€1.2b 3.28%
Unlock
2027
€1.3b 2.42%
Unlock

4 Analysts have issued an CompuGroup Medical EBITDA forecast 2025. The average CompuGroup Medical EBITDA estimate is

€239m
Unlock
. This is
8.41% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€252m 14.64%
Unlock
, the lowest is
€228m 3.70%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €201m 25.72%
2025
€239m 18.58%
Unlock
2026
€256m 7.10%
Unlock
2027
€262m 2.68%
Unlock
2028
€258m 1.70%
Unlock
2029
€267m 3.49%
Unlock

EBITDA Margin

2024 17.44% 23.55%
2025
20.03% 14.84%
Unlock
2026
20.77% 3.69%
Unlock
2027
20.82% 0.24%
Unlock

3 CompuGroup Medical Analysts have issued a net profit forecast 2025. The average CompuGroup Medical net profit estimate is

€55.5m
Unlock
. This is
60.19% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€61.1m 76.11%
Unlock
, the lowest is
€48.1m 38.81%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €34.7m 23.86%
2025
€55.5m 60.19%
Unlock
2026
€68.3m 23.00%
Unlock
2027
€80.5m 17.80%
Unlock

Net Margin

2024 3.00% 21.64%
2025
4.66% 55.13%
Unlock
2026
5.55% 19.10%
Unlock
2027
6.38% 14.95%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share 0.67 1.07
23.86% 59.70%
P/E 20.55
EV/Sales 1.61

3 Analysts have issued a CompuGroup Medical forecast for earnings per share. The average CompuGroup Medical EPS is

€1.07
Unlock
. This is
59.70% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€1.18 76.12%
Unlock
, the lowest is
€0.93 38.81%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €0.67 23.86%
2025
€1.07 59.70%
Unlock
2026
€1.32 23.36%
Unlock
2027
€1.56 18.18%
Unlock

P/E ratio

Current 45.37 56.29%
2025
20.55 54.71%
Unlock
2026
16.71 18.69%
Unlock
2027
14.19 15.08%
Unlock

Based on analysts' sales estimates for 2025, the CompuGroup Medical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.66 7.26%
2025
1.61 3.22%
Unlock
2026
1.56 3.17%
Unlock
2027
1.52 2.36%
Unlock

P/S ratio

Current 0.99 19.59%
2025
0.96 3.16%
Unlock
2026
0.93 3.17%
Unlock
2027
0.91 2.36%
Unlock

Current CompuGroup Medical Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Mar 31 2025
LANDESBANK BADEN-WUERTTEMBERG
Locked
Locked
Locked Mar 30 2025
BAADER HELVEA EQUITY RESEARCH
Locked
Locked
Locked Mar 17 2025
LANDESBANK BADEN-WUERTTEMBERG
Locked
Locked
Locked Mar 10 2025
MWB RESEARCH AG
Locked
Locked
Locked Mar 09 2025
JEFFERIES
Locked
Locked
Locked Mar 05 2025
BERENBERG
Locked
Locked
Locked Dec 09 2024
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Mar 31 2025
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
Locked
Mar 30 2025
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
Locked
Mar 17 2025
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
Locked
Mar 10 2025
Locked
MWB RESEARCH AG:
Locked
Locked
Mar 09 2025
Locked
JEFFERIES:
Locked
Locked
Mar 05 2025
Locked
BERENBERG:
Locked
Locked
Dec 09 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today